Learn More
CERILLIANT™ Lurasidone-D8 Hydrochloride Solution, 100 μg/mL in Methanol (as free base), Sold by MilliporeSigma™ Supelco™
Certified reference material
Supplier: MilliporeSigma Supelco L0351ML
Description
Marketed under the trade name Latuda™, Lurasidone is a new atypical antipsychotic developed for the treatment of schizophrenia. This stable-labeled internal standard is suitable for use in LC/MS or GC/MS applications including clinical toxicology, forensic testing, or pharmaceutical research.
Specifications
| 75-05-8 | |
| UN 1648 3 / PGII | |
| 537.19 | |
| 1 mL |
| C28H28D8N4O2S · HCl | |
| 100 μg/mL in methanol (as free base) | |
| Ampule |
Safety and Handling
EINECSNumber : 200-835-2
Recommended Storage : -20°C
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
CERILLIANT is a registered trademark of Cerilliant Corporation